Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002

Gemma Gatta, Silvia Rossi, Roberto Foschi, Annalisa Trama, Rafael Marcos-Gragera, Guido Pastore, Rafael Peris-Bonet, Charles Stiller, Riccardo Capocaccia

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Proportion cured is a potentially more informative cancer outcome measurement than 5-year survival. We present population-based estimates of cure for young patients diagnosed with acute lymphoblastic leukemia in Europe from 1982 to 2002. Thirty-five European cancer registries provided data. Survival was estimated by age, period of diagnosis and European region, and used as input for parametric cure models, which assume cured patients have the same mortality as the general population. For acute lymphoblastic leukemia diagnosed in 1-14 year olds in 2000-2002, over 77% were estimated cured. The proportion cured improved significantly over the study period: an impressive 26-58% in infants (up to 1 year), 70-90% in 1-4 year olds, 63-86% in 5-9 year olds, 52-77% in 10-14 year olds, and 44-50% in 15-24 year olds. Regional variations in proportion cured reduced over time for 1-14 year-olds, but persisted in infants and 15-24 year olds. Five-year survival was always slightly higher than proportion cured. Considerable proportions of young patients were estimated cured of acute lymphoblastic leukemia. Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries.

Original languageEnglish
Pages (from-to)744-752
Number of pages9
JournalHaematologica
Volume98
Issue number5
DOIs
Publication statusPublished - 2013

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Young Adult
Survival
Population
Registries
Neoplasms
Recurrence
Mortality
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. / Gatta, Gemma; Rossi, Silvia; Foschi, Roberto; Trama, Annalisa; Marcos-Gragera, Rafael; Pastore, Guido; Peris-Bonet, Rafael; Stiller, Charles; Capocaccia, Riccardo.

In: Haematologica, Vol. 98, No. 5, 2013, p. 744-752.

Research output: Contribution to journalArticle

Gatta, Gemma ; Rossi, Silvia ; Foschi, Roberto ; Trama, Annalisa ; Marcos-Gragera, Rafael ; Pastore, Guido ; Peris-Bonet, Rafael ; Stiller, Charles ; Capocaccia, Riccardo. / Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002. In: Haematologica. 2013 ; Vol. 98, No. 5. pp. 744-752.
@article{f30d6cb8b71f4411b1b41e564c43901d,
title = "Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002",
abstract = "Proportion cured is a potentially more informative cancer outcome measurement than 5-year survival. We present population-based estimates of cure for young patients diagnosed with acute lymphoblastic leukemia in Europe from 1982 to 2002. Thirty-five European cancer registries provided data. Survival was estimated by age, period of diagnosis and European region, and used as input for parametric cure models, which assume cured patients have the same mortality as the general population. For acute lymphoblastic leukemia diagnosed in 1-14 year olds in 2000-2002, over 77{\%} were estimated cured. The proportion cured improved significantly over the study period: an impressive 26-58{\%} in infants (up to 1 year), 70-90{\%} in 1-4 year olds, 63-86{\%} in 5-9 year olds, 52-77{\%} in 10-14 year olds, and 44-50{\%} in 15-24 year olds. Regional variations in proportion cured reduced over time for 1-14 year-olds, but persisted in infants and 15-24 year olds. Five-year survival was always slightly higher than proportion cured. Considerable proportions of young patients were estimated cured of acute lymphoblastic leukemia. Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries.",
author = "Gemma Gatta and Silvia Rossi and Roberto Foschi and Annalisa Trama and Rafael Marcos-Gragera and Guido Pastore and Rafael Peris-Bonet and Charles Stiller and Riccardo Capocaccia",
year = "2013",
doi = "10.3324/haematol.2012.071597",
language = "English",
volume = "98",
pages = "744--752",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "5",

}

TY - JOUR

T1 - Survival and cure trends for European children, adolescents and young adults diagnosed with acute lymphoblastic leukemia from 1982 to 2002

AU - Gatta, Gemma

AU - Rossi, Silvia

AU - Foschi, Roberto

AU - Trama, Annalisa

AU - Marcos-Gragera, Rafael

AU - Pastore, Guido

AU - Peris-Bonet, Rafael

AU - Stiller, Charles

AU - Capocaccia, Riccardo

PY - 2013

Y1 - 2013

N2 - Proportion cured is a potentially more informative cancer outcome measurement than 5-year survival. We present population-based estimates of cure for young patients diagnosed with acute lymphoblastic leukemia in Europe from 1982 to 2002. Thirty-five European cancer registries provided data. Survival was estimated by age, period of diagnosis and European region, and used as input for parametric cure models, which assume cured patients have the same mortality as the general population. For acute lymphoblastic leukemia diagnosed in 1-14 year olds in 2000-2002, over 77% were estimated cured. The proportion cured improved significantly over the study period: an impressive 26-58% in infants (up to 1 year), 70-90% in 1-4 year olds, 63-86% in 5-9 year olds, 52-77% in 10-14 year olds, and 44-50% in 15-24 year olds. Regional variations in proportion cured reduced over time for 1-14 year-olds, but persisted in infants and 15-24 year olds. Five-year survival was always slightly higher than proportion cured. Considerable proportions of young patients were estimated cured of acute lymphoblastic leukemia. Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries.

AB - Proportion cured is a potentially more informative cancer outcome measurement than 5-year survival. We present population-based estimates of cure for young patients diagnosed with acute lymphoblastic leukemia in Europe from 1982 to 2002. Thirty-five European cancer registries provided data. Survival was estimated by age, period of diagnosis and European region, and used as input for parametric cure models, which assume cured patients have the same mortality as the general population. For acute lymphoblastic leukemia diagnosed in 1-14 year olds in 2000-2002, over 77% were estimated cured. The proportion cured improved significantly over the study period: an impressive 26-58% in infants (up to 1 year), 70-90% in 1-4 year olds, 63-86% in 5-9 year olds, 52-77% in 10-14 year olds, and 44-50% in 15-24 year olds. Regional variations in proportion cured reduced over time for 1-14 year-olds, but persisted in infants and 15-24 year olds. Five-year survival was always slightly higher than proportion cured. Considerable proportions of young patients were estimated cured of acute lymphoblastic leukemia. Nevertheless, a small excess risk of death persisted beyond five years after diagnosis when patients remained at risk for late treatment effects, late relapses and second primaries.

UR - http://www.scopus.com/inward/record.url?scp=84877028322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877028322&partnerID=8YFLogxK

U2 - 10.3324/haematol.2012.071597

DO - 10.3324/haematol.2012.071597

M3 - Article

C2 - 23403323

AN - SCOPUS:84877028322

VL - 98

SP - 744

EP - 752

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 5

ER -